Genalyte Raises $44M in Series C Financing

Aug 18, 2015

|

NEW YORK (GenomeWeb) – San Diego-based diagnostics firm Genalyte today announced it has completed a $44M Series C financing round.

Khosla Ventures joined previous investors Redmile Group, Claremont Creek Ventures, and BioMed Ventures in the round.

Genalyte's CE-marked Maverick Detection System is intended for multiplexed, blood-based, point-of-care diagnostic testing. The firm said in a statement that it can provide results in 15 minutes. The platform is for research use only in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Same Scam, New Tech

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

Gene Therapy for SCID-X1

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

To Guide the Genealogy Search

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

This Week in Nature

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Menu